Centrexion Therapeutics to Present at the 19th Annual BIO CEO & Investor Conference

Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest exclusively pain-focused pipelines of non-opioid therapies in active development, today announced its participation in the 19th Annual BIO CEO & Investor Conference taking place February 13-14 at the Waldorf Astoria hotel in New York City.

This entry was posted in Recent Development News: Q1 - 2017, Recent Developments. Bookmark the permalink.
Read Full Article »